Key facts
- This page summarizes Christopher Krawtschuk's Form 4 filing for bluebird bio, Inc. (BLUE).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Dec 2022, 15:49.
Christopher Krawtschuk - 01 Dec 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- BLUE
- Reported as of
- 01 Dec 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Dec 2022, 15:49:28 UTC
- Prior SEC filing
- 07 Nov 2022
- Next SEC filing
- 08 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Krawtschuk
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher Krawtschuk filed Form 4 for bluebird bio, Inc. (BLUE) on 05 Dec 2022.
Change
- Previous filing in this sequence was filed on 07 Nov 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLUE
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 01 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BLUE
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 01 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $7.61
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock unit awards vest over a four-year period at the rate of 25% on 12/1/2023, 25% on 12/1/2024, 25% on 12/1/2025, and 25% on 12/1/2026.
Footnote F2
The stock option vests over a four-year period at the rate of 25% on 12/1/2023 and then in 36 equal monthly installments thereafter.